Resonex Medical Technologies is a North American leader in Ion Cyclotron Resonance (ICR) therapy, delivering clinically developed European technology supported by over three decades of research in bioelectrics, physiology, and regenerative science.

ICR technology works at the cellular level by delivering precisely calibrated electromagnetic frequencies designed to support cellular fluidity and optimal mitochondrial function.

As cells age or experience environmental stress, cellular structures can become increasingly rigid, reducing efficiency in energy production and biological communication. ICR therapy helps restore cellular dynamics by promoting a more fluid intracellular environment, allowing mitochondria — the cell’s energy producers — to function more effectively.

Improved mitochondrial activity supports:

• Reduced inflammation

• Enhanced microcirculation

• Muscle relaxation

• Pain modulation

• Cellular recovery processes

Rather than forcing biological change, ICR technology supports the body’s natural regenerative capacity by optimizing the internal conditions required for self-repair.

Resonex exists to deliver advanced therapeutic technologies that help restore biological balance in an increasingly demanding modern environment.